Israeli Start-Up Healium Medical Receives the Prestigious ICI 2019 Innovation Award for Atrial Fibrillation Treatment

Piezo Ultrasound Elements from PI Are Used for the Award-Winning Treatment Method

Healium Medical was named 1st Prize-Winner of the ICI 2019 Innovation Award Competition (Innovation in Cardiovascular Interventions). Ran Sela, CEO and founder of Healium Medical proudly received $ 100,000 in prize money for its new treatment technology of atrial fibrillation. Piezo ultrasound elements from PI play an important role in the new treatment method. The prize was sponsored by the Jon DeHaan Foundation and presented at the David International Convention Center, Tel Aviv, on December 10, 2019, during the ICI Meeting.

Atrial Fibrillation

Atrial fibrillation (AF) is the most common cardiac arrhythmia or rhythm abnormality. AF is an irregular and often rapid heart rate that may cause symptoms like heart palpitations, fatigue, and shortness of breath. Currently, more than 46 million patients worldwide suffer from this potentially fatal disease. AF occurs when the upper chambers of the heart (atria) beat rapidly and irregularly (fibrillate). This can cause blood to pool and form clots in an area of the heart called the left atrial appendage (LAA). When a blood clot escapes from the LAA and travels to another part of the body it can cause a stroke. These who have AF are 5 times more likely to suffer a stroke than someone with a regular heartbeat. Fortunately, AF may be treated with medication, cardioversion or a catheter ablation procedure. However, despite the large number of advances in the field over the past two decades, AF remains a substantial cause of mortality and morbidity.

New Treatment Method

Healium Medical has now developed a non-contact guided ablation system for the treatment of this disease. The company develops transcatheter ultrasound technology enabling rapid, non-contact circumferential pulmonary vein isolation with real-time lesion monitoring. The goal is to improve procedure efficacy, simplify procedure flow and shorten procedure time. Healium Medical’s solution addresses the key limitations of the technology currently used in AF ablation by allowing no-tissue contact and gap free ablation with real-time lesion quality assessment. The Contactless Guided Ablation technology leverages ultrasound energy to deliver and monitor the precise energy needed for safe and rapid lesion formation around the pulmonary veins. For that purpose the ultrasonic transducers from PI Ceramic are used.

About Healium Medical

Healium Medical was founded in 2017 by Ran Sela MSc in Biomedical Engineering from the Grove School of Engineering, New York and by Shimon Eckhouse, PhD.

The start-up company operates out of Yokneam, Israel, has a full scale in-house R&D lab, employs a multidisciplinary team of physicists, engineers & physicians and has pre-clinical data supporting the feasibility of its proprietary technology.

À propos de cet auteur

Dr. Thomas Bocher

Head of the Life Science & Microscopy Market Segment, Physik Instrumente (PI) GmbH & Co. KG

Plus de publications de cet auteur

À propos de cet auteur

Markus Wiederspahn

Global Campaign Manager, Physik Instrumente (PI) GmbH & Co. KG

Plus de publications de cet auteur